Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation
about
Deep resequencing of the voltage-gated potassium channel subunit KCNE3 gene in chronic tinnitusMuscle channelopathies and critical points in functional and genetic studies.Gain-of-function mutations in potassium channel subunit KCNE2 associated with early-onset lone atrial fibrillationThe genetic basis of Brugada syndrome: a mutation updateDisruption of the K+ channel beta-subunit KCNE3 reveals an important role in intestinal and tracheal Cl- transportGenotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysisDiagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre.Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family.Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes.The KCNE genes in hypertrophic cardiomyopathy: a candidate gene study.Ion channels: function unravelled by dysfunction.Molecular diagnosis of inheritable neuromuscular disorders. Part II: Application of genetic testing in neuromuscular disease.The primary periodic paralyses: diagnosis, pathogenesis and treatment.Paroxysmal muscle weakness: the familial periodic paralyses.Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder.A novel mutation in CACNA1S gene associated with hypokalemic periodic paralysis which has a gender difference in the penetrance.Targeted deletion of Kcne3 impairs skeletal muscle function in mice.
P2860
Q21203797-3E68C0D9-4A06-49D3-84E9-B9FEAA32F866Q24532297-4CDCCC25-67C6-48BF-84C8-F71952894648Q28239461-06E3EF9F-10CF-4D46-BC6A-E297D964864FQ28252115-E7690352-6900-410C-8920-618E798EDC9BQ28269452-C83FB660-93F8-4167-B588-CF568ED6DB0AQ28295660-F83556B3-FCA6-49B2-905D-BD092A60B1ECQ33807683-2C7BDF23-0B34-4F4D-BAE5-F4D7351490F8Q35054061-FF494342-13CB-4B1A-8E82-171EF7E8D6D4Q35449040-67BFD457-A0E7-4F73-BECC-0F44AFDBFB70Q35478355-D70F7198-B7B8-4A53-952C-437AFACBAF1EQ35934207-9E5F69B2-12FF-4EEC-9F28-E8DBD944CC34Q36036959-AA808436-ACDB-4C62-BCA4-11803E25BFDCQ36272858-377B4C2E-D1AD-44EC-B558-C1C1204C0F6DQ36670607-5DED0BDF-4121-44AA-903B-3CCF29B46899Q36774708-A9CB45F8-D2DF-4021-AF70-6451FE52AAE7Q45981184-9534454E-E707-4613-A6A7-B34D72273381Q46051848-CE7C15E2-409B-46D5-A586-079DABC3DFF7
P2860
Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Periodic paralysis mutation Mi ...... ons and general recommendation
@ast
Periodic paralysis mutation Mi ...... ons and general recommendation
@en
Periodic paralysis mutation Mi ...... ons and general recommendation
@nl
type
label
Periodic paralysis mutation Mi ...... ons and general recommendation
@ast
Periodic paralysis mutation Mi ...... ons and general recommendation
@en
Periodic paralysis mutation Mi ...... ons and general recommendation
@nl
prefLabel
Periodic paralysis mutation Mi ...... ons and general recommendation
@ast
Periodic paralysis mutation Mi ...... ons and general recommendation
@en
Periodic paralysis mutation Mi ...... ons and general recommendation
@nl
P1433
P1476
Periodic paralysis mutation Mi ...... ons and general recommendation
@en
P2093
Frank Lehmann-Horn
P304
P356
10.1212/01.WNL.0000119392.29624.88
P407
P577
2004-03-23T00:00:00Z